Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder

Bilici, Meki; Demir, Fikri; Akın, Alper; Türe, Mehmet; Balık, Hasan; Kuyumcu, Mahir
December 2017
Pediatric Cardiology;Dec2017, Vol. 38 Issue 8, p1598
Academic Journal
The aim of this study was to evaluate the feasibility, efficacy and safety of transcatheter closure of patent ductus arteriosus (PDA) with the Occlutech duct occluder (ODO) in children. We reviewed the clinical records of 71 patients who underwent percutaneous closure of PDA with an ODO between September 2014 and August 2016. The Occlutech duct occluder was applied to 71 patients during the study period (September 2014-August 2016), and the results were analyzed in this study. Forty-two of the patients were female and 29 male. The median age was 20.5 months (range, 6-194 months) and median weight was 16 kg (range, 6-68 kg). The PDA was classified as type A in 54 patients (76.1%), type E in 14 (19.7%), type C in 2 (2.8%) and type B in 1 (1.4%) based on the Krichenko classification. A standard ODO device was used for the transcatheter closure procedure in 66 patients and the long-shank ODO device in 5. In the echocardiographic measurement of PDA, the median smallest diameter was 2.7 mm (range, 1.5-7.0 mm), and in the angiographic measurement, the median smallest diameter was 2.5 mm (range, 1.5-6.5 mm). All 71 patients underwent successful PDA closure with the ODO. Angiography following the procedure showed complete closure in 47 patients (66.2%), mild residual shunt in 13 patients (18.3%) and a trivial shunt in 11 patients (15.5%). Color flow Doppler echocardiogpaphy at 24 h post-implantation showed that complete closure was achieved in 65 patients (91.5%), and 6 patients (8.5%) had mild residual shunt. All patients (100%) had complete closure at 30 days of follow-up. The results of this study showed that the Occlutech PDA occluder device is safe and effective in the closure of PDA. As the pulmonary artery side of the device is wider than the aortic side, protrusion toward the aortic side and embolization are prevented, but there is residual shunt in the early period, although this residual shunt disappeared after a few months.


Related Articles

  • Percutaneous Closure of a Moderate to Large Tubular or Elongated Patent Ductus Arteriosus in Children Younger Than 3 Years: Is the ADO II Appropriate? Kumar, Saktheeswaran; Subramanian, Venkateshwaran; Bijulal, Sasidharan; Krishnamoorthy, Kavassery; Sivasankaran, Sivasubramonian; Tharakan, Jaganmohan // Pediatric Cardiology;Oct2013, Vol. 34 Issue 7, p1661 

    Protrusion of the Amplatzer duct occluder (ADO) II device into the aortic isthmus or the pulmonary artery causing obstruction and residual flow has been reported, but the same has not been widely studied in small children with a patent ductus arteriosus (PDA) anatomy not considered suitable for...

  • Transcatheter Closure of the Patent Ductus Arteriosus: An Intention to Treat Analysis. Sheridan, Bennett J.; Ward, Cameron J.; Anderson, Benjamin W.; Justo, Robert N. // Heart, Lung & Circulation;Jun2013, Vol. 22 Issue 6, p428 

    Background: In patients with patent ductus arteriosus (PDA), transcatheter closure is the current procedure of choice. There are multiple devices available with limited current comparative data and varied recommendations for device selection. Objective: To assess the efficacy and safety of the...

  • EriÅŸkin bir Olguda Patent Duktus Arteriozus'un Transkateter Yöntem ile Tedavisi. Güntürk, Ertuðrul Emre; Yarlýoðlueþ, Mikail; Kaya, Mehmet Güngör; Günebakmaz, özgür; Baykan, Ali // Erciyes Medical Journal / Erciyes Tip Dergisi;2010, Vol. 32 Issue 2, p139 

    A forty-year-old woman suffering from palpitation for six months was admitted to cardiology clinic. Continuous murmur was heard on left subclavian space on physical examination. Normal sinus rhythm and left ventricular hypertrophy signs were present in her electrocardiography. In...

  • Device closure of patent ductus arteriosus: optimal guidance by transaortic phased-array imaging. Bartel, Thomas; Gliech, Volker; Müller, Silvana // European Journal of Echocardiography;Feb2011, Vol. 12 Issue 2, pE9 

    In many institutions, device closure of patent ductus arteriosus (PDA) in adult patients is only performed once to twice per year. This report describes an interventional PDA closure procedure being effectively assisted by transaortic phased-array imaging, also known as intracardiac...

  • Modern treatment of patent ductus arteriosus - Single center experience. Dinarević, Senka; Kadić, Almira; Begić, Zijo; Halimić, Mirza; Vukas, Emina // Journal of Health Sciences;2014, Vol. 4 Issue 3, p181 

    Introduction: Transcatheter closure is a treatment choice for the most children with patent ductus arteriosus (PDA). The closure of the ductus is indicated in any child or adolescent with developed symptoms of significant L-R shunt. The aim of this article is to present our results in 5 years...

  • Congenital coronary arteriovenous fistulae in a transplanted heart. Cannarile, Pierpaolo; Iadanza, Alessandro; Mondillo, Sergio; Pierli, Carlo // International Journal of Cardiovascular Imaging;Dec2014, Vol. 30 Issue 8, p1419 

    We report a very rare case of a heart transplanted man with angiographic documentation of multiple congenital fistulae arising from both coronary arteries and draining into main pulmonary artery. A transthoracic echocardiogram and right heart catheterization were also performed, to assess the...

  • A case with patent ductus arteriosus and coarctation of aorta where aberrant right subclavian artery originates from the coarcted segment: Our successful surgical approach. Gurbuz, Ali; Lafci, Banu; AKSUN, Murat; MESE, Timur; Yetkin, Ufuk // Internet Journal of Thoracic & Cardiovascular Surgery;2009, Vol. 14 Issue 1, p8 

    About 1% of live born children have congenital heart defects.In this study we present a case with patent ductus arteriosus and coarctation of aorta where aberrant right subclavian artery originates from the coarcted segment and our successful surgical approach.

  • Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta--A Prospective Study. Eerola, Anneli; Jokinen, Eero; Boldt, Talvikki; Mattila, Ilkka P.; Pihkala, Jaana I. // International Journal of Pediatrics;2010, p1 

    Background and Objectives. We evaluated and compared the influence of treatment for atrial septal defect (ASD), patent ductus arteriosus (PDA), and coarctation of the aorta (CoA) on serum levels of N-terminal proatriopeptide and N-terminal probrain natriuretic peptide. Correlations between...

  • Natural evolution of patent ductus arteriosus in the extremely preterm infant. Rolland, Audrey; Shankar-Aguilera, Shivani; Diomandé, Douty; Zupan-Simunek, Véronique; Boileau, Pascal // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2014, Vol. 100 Issue 1, pF55 

    Objective The persistence of the patent ductus arteriosus (PDA) is frequently encountered in very preterm infants. Neither preventive nor curative treatments of PDA have been shown to improve the outcome of these infants. Since no consensus on optimal treatment of PDA is established, we...

  • Para Cierre del Ductus Arterioso Permeable con Ibuprofeno por Vía Enteral. Servicio de Neonatología Hospital Infantil del Estado de Sonora. Rojas-Villalvazo, José Manuel; Ramírez-Rodríguez, Carlos Arturo; Sosa-Cruz, Erika Flor; Corella-Valencia, Jaime // Boletin Clinico Hospital Infantil del Estado de Sonora;Sep2013, Vol. 30 Issue 2, p76 

    Introduction: Patent ductusarteriosus (PDA) is the most common cardiocirculatory defects in preterm infants . It has an incidence of 80% in less than 1,000 g and / or 28 weeks gestation. A hemodynamically significant patent ductusarteriosus (PDA-HS) is symptomatic and evidenced by echocardiogram...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics